Drug-induced hypersensitivity syndrome: Recent advances in drug allergy

Expert Review of Dermatology

Volumn 7, Issue 6, 2012, Pages 539-547

  Shiohara, Tetsuo ^a   Kano, Yoko ^a  

^a KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

autoimmune diseases; drug induced hypersensitivity syndrome; Treg; viral reactivations

Indexed keywords

ABACAVIR; ALLOPURINOL; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CORTICOSTEROID; DAPSONE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LAMOTRIGINE; MEXILETINE; MINOCYCLINE; NEVIRAPINE; PHENOBARBITAL; PHENYTOIN; PREDNISOLONE; SALAZOSULFAPYRIDINE; ZONISAMIDE;

AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CELL FUNCTION; CLINICAL FEATURE; DRESS SYNDROME; DRUG CROSS REACTIVITY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; EOSINOPHILIA; GENE FREQUENCY; GENETICS; HUMAN; HUMAN HERPESVIRUS 6; IMMUNOGLOBULIN BLOOD LEVEL; IN VITRO STUDY; INTERSTITIAL PNEUMONIA; LYMPHOCYTE TRANSFORMATION TEST; OUTCOME ASSESSMENT; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SKIN MANIFESTATION; STEVENS JOHNSON SYNDROME; T LYMPHOCYTE ACTIVATION; TOXIC EPIDERMAL NECROLYSIS;

EID: 84870908099     PISSN: 17469872     EISSN: 17469880     Source Type: Journal    
DOI: 10.1586/edm.12.45     Document Type: Review

References (37)

1. MockenhauPTM. Epidemiology of cutaneous adverse drug reactions. Chem. Immunol. Allergy 97, 1-17 (2012
2. Shiohara T, Kano Y, Takahashi R, Ishida T, Mizukawa Y. Drug-Induced hypersensitivity syndrome: Recent advances in the diagnosis, pathogenesis and management. Chem. Immunol. Allergy 97, 122-138 (2012
3. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N. Engl. J. Med. 331(19), 1272-1285 (1994
4. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch. Dermatol. 129(1), 92-96 (1993
5. MockenhauPTM, Viboud C, Dunant A et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: Assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J. Invest. Dermatol. 128(1), 35-44 (2008
6. Harr T, French LE. Stevens-Johnson syndrome and toxic epidermal necrolysis. Chem. Immunol. Allergy 97, 149-166 (2012
7. Merritt HH, Putnam TJ. Sodium diphenylhydantoinate in the treatment of convulsive disorders. JAMA 111, 1068-1073 (1938
8. Chaiken BH, Goldberg BI, Segal JP. Dilantin sensitivity; report of a case of hepatitis with jaundice, pyrexia and exfoliative dermatitis. N. Engl. J. Med. 242(23), 897-898 (1950
9. Shear NH, Spielberg SP. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. J. Clin. Invest. 82(6), 1826-1832 (1988
10. Bocquet H, Bagot M, Roujeau JC. Drug-Induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS). Semin. Cutan. Med. Surg. 15(4), 250-257 (1996
11. Suzuki Y, Inagi R, Aono T, Yamanishi K, Shiohara T. Human herpesvirus 6 infection as a risk factor for the development of severe drug-Induced hypersensitivity syndrome. Arch. Dermatol. 134(9), 1108-1112 (1998
12. Tohyama M, Yahata Y, Yasukawa M et al. Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. Arch. Dermatol. 134(9), 1113-1117 (1998
13. Tohyama M, Hashimoto K, Yasukawa M et al. Association of human herpesvirus 6 reactivation with the flaring and severity of drug-Induced hypersensitivity syndrome. Br. J. Dermatol. 157(5), 934-940 (2007
14. Shiohara T, Inaoka M, Kano Y. Drug-Induced hypersensitivity syndrome (DIHS): A reaction induced by a complex interplay among herpes viruses and antiviral and antidrug immune responses. Allergol. Int. 55(1), 1-8 (2006
15. Shiohara T, Iijima M, Ikezawa Z, Hashimoto K. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br. J. Dermatol. 156(5), 1083-1084 (2007
16. Kardaun SH, Sidoroff A, Valeyrie-Allanore L et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: Does a DRESS syndrome really exist? Br. J. Dermatol. 156(3), 609-611 (2007
17. Kano Y, Shiohara T. The variable clinical picture of drug-Induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug. Immunol. Allergy Clin. North Am. 29(3), 481-501 (2009
18. Sakuma K, Kano Y, Fukuhara M, Shiohara T. Syndrome of inappropriate secretion of antidiuretic hormone associated with limbic encephalitis in a patient with drug-Induced hypersensitivity syndrome. Clin. Exp. Dermatol. 33(3), 287-290 (2008
19. Horneff G, Lenard HG, Wahn V. Severe adverse reaction to carbamazepine: Significance of humoral and cellular reactions to the drug. Neuropediatrics 23(5), 272-275 (1992
20. Kano Y, Inaoka M, Shiohara T. Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia. Arch. Dermatol. 140(2), 183-188 (2004
21. Kano Y, Hiraharas K, Sakuma K, Shiohara T. Several herpes viruses can reactivate in a severe drug-Induced multiorgan reaction in the same sequential order as in graft-versushost disease. Br. J. Dermatol. 155(2), 301-306 (2006
22. Kano Y, Hirahara K, Mitsuyama Y, Takahashi R, Shiohara T. Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: Dependence on its timing and the type of drug eruption. Allergy 62(12), 1439-1444 (2007
23. Chung WH, Hung SI, Hong HS et al. Medical genetics: A marker for Stevens-Johnson syndrome. Nature 428(6982), 486 (2004
24. Dainichi T, Uchi H, Moroi Y, Furue M. Stevens-Johnson syndrome, drug-Induced hypersensitivity syndrome and toxic epidermal necrolysis caused by allopurinol in patients with a common HLA allele: What causes the diversity? Dermatology (Basel) 215(1), 86-88 (2007
25. Kano Y, Hirahara K, Asano Y, Shiohara T. HLA-B allele associations with certain drugs are not confirmed in Japanese patients with severe cutaneous drug reactions. Acta Derm. Venereol. 88(6), 616-618 (2008
26. Hung S-I, Chung W-H, Liou L-B et al. HLA-B.5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc. Natl Acad. Sci. USA 102, 4134-4139 (2005
27. Kang HR, Jee YK, Kim YS et al. Positive and negative associations of HLA class I alleles with allopurinol-Induced SCARs in Koreans. Pharmacogenet Genomics. 21, 303-307 (2011
28. Ozeki T, Mushiroda T, Yowang A et al. Genome-Wide association study identifies HLA-A.3101 allele as a genetic risk factor for carbamazepine-Induced cutaneous adverse drug reactions in Japanese population. Hum. Mol. Genet. 20(5), 1034-1041 (2011
29. McCormack M, Alfirevic A, Bourgeois S et al. HLA-A.3101 and carbamazepineinduced hypersensitivity reactions in Europeans. N. Engl. J. Med. 364(12), 1134-1143 (2011
30. Picard D, Janela B, Descamps V et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): A multiorgan antiviral T cell response. Sci. Transl. Med. 2, 46-62 (2010
31. Takahashi R, Kano Y, Yamazaki Y, Kimishima M, Mizukawa Y, Shiohara T. Defective regulatory T cells in patients with severe drug eruptions: Timing of the dysfunction is associated with the pathological phenotype and outcome. J. Immunol. 182(12), 8071-8079 (2009
32. Kano Y, Sakuma K, Shiohara T. Sclerodermoid graft-versus-host diseaselike lesions occurring after drug-Induced hypersensitivity syndrome. Br. J. Dermatol. 156(5), 1061-1063 (2007
33. Aota N, Shiohara T. Viral connection between drug rashes and autoimmune diseases: How autoimmune responses are generated after resolution of drug rashes. Autoimmun. Rev. 8(6), 488-494 (2009
34. Shiohara T, Takahashi R, Kano Y. Drug-Induced hypersensitivity syndrome and viral infection. In: Drug Hypersensitivity. Pichler WJ (Ed.). Karger, Basel, Switzerland, 251-266 (2007
35. Asano Y, Kagawa H, Kano Y, Shiohara T. Cytomegalovirus disease during severe drug eruptions: Report of 2 cases and retrospective study of 18 patients with drug-Induced hypersensitivity syndrome. Arch. Dermatol. 145(9), 1030-1036 (2009
36. Jevtovic DJ, Salemovic D, Ranin J, Pesic I, Zerjav S, Djurkovic-Djakovic O. The prevalence and risk of immune restoration disease in HIV-Infected patients treated with highly active antiretroviral therapy. HIV Med. 6(2), 140-143 (2005
37. Shiohara T, Kurata M, Mizukawa Y, Kano Y. Recognition of immune reconstitution syndrome necessary for better management of patients with severe drug eruptions and those under immunosuppressive therapy. Allergol. Int. 59(4), 333-343 (2010